Patent Opportunities In FDA Bispecific Antibody Guidance
In April 2019, the U.S. Food and Drug Administration published draft guidance entitled "Bispecific Antibody Development Programs Guidance for Industry" that provides "recommendations to assist industry and other parties involved in...To view the full article, register now.
Already a subscriber? Click here to view full article